Find Academic Supervisors

J.A.M.J.L. Janssen is a Researcher in the Department of Internal Medicine at Erasmus MC, a leading academic medical center in the Netherlands. The research profile indicates active contributions to the fields of endocrinology, metabolism, and molecular medicine. The research interests of J.A.M.J.L. Janssen center on metabolic syndrome , type 2 diabetes , ectopic fat deposition , hyperinsulinemia , and the insulin/IGF-I signaling pathway . Additional focus includes receptor pharmacology , particularly the interplay between IGF-I and TSH receptors in thyroid eye disease. Research also extends to overnutrition , ultra-processed foods , and the metabolic consequences of Westernization. These interests are reflected in a high volume of recent review articles and commentaries in prominent journals. The recent publications demonstrate a strong trend toward synthesizing evidence on metabolic dysregulation, advocating for paradigm shifts in diabetes management, and exploring molecular mechanisms of disease. Work frequently appears in journals such as International Journal of Molecular Sciences and The Lancet Regional Health - Europe , indicating high impact and policy relevance. While no specific scientific awards are listed in the provided text, the research has been cited extensively (e.g., 38 citations for a 2022 article) and picked up by multiple news outlets and blogs, suggesting recognition in both academic and public spheres. J.A.M.J.L. Janssen has supervised at least three research projects, as indicated by the 'Supervised Work (3)' metric, though specific student names and grant details are not available. The scholarly output includes collaborations with international researchers, such as L. Girnita and T.J. Smith. The research is conducted within the Department of Internal Medicine at Erasmus MC, with no additional lab or team structure described in the text.

• Metabolic Syndrome
• Type 2 Diabetes
• Insulin/IGF-I Signaling Pathway
• +12 more

Willem Pieter Brouwer is a Researcher at Erasmus MC's Department of Gastroenterology & Hepatology, focusing on advanced liver disease research. His work addresses chronic hepatitis B, liver fibrosis, metabolic dysfunction-associated steatotic liver disease (MASLD), and the interplay between metabolic disorders and viral infections. He has contributed to 64 peer-reviewed publications, including studies on diagnostic accuracy of liver stiffness assessment and global epidemiology of liver diseases. Key research interests include the molecular mechanisms of liver disease progression, non-invasive diagnostic tools, and the impact of obesity on liver pathology. Collaborations span global institutions, addressing public health implications of viral and metabolic liver diseases. His studies often employ systematic reviews and meta-analyses to synthesize large-scale epidemiological data.

• Hepatology
• Liver Diseases
• Chronic Hepatitis B
• +3 more

Dr. Saer Samanipour is a Visiting Professor at the Van 't Hoff Institute for Molecular Sciences, part of the Faculty of Science at the University of Amsterdam. His research focuses on advanced analytical techniques for environmental and biomedical applications, with a strong emphasis on non-targeted analysis, mass spectrometry, and machine learning integration. He leads efforts in developing open-source tools like GcDUO and jHRMSToolBox to enhance data interpretation in complex chemical datasets. Key areas include environmental contaminant detection, chemical exposure assessment via wastewater-based epidemiology, and proteomic analysis of snake venoms. His work bridges computational methods with experimental chemistry to address global challenges in environmental health and toxicology. Primary affiliation: Van 't Hoff Institute for Molecular Sciences Research themes: Non-targeted LC-HRMS workflows, machine learning applications in analytical chemistry, PFAS analysis, and exposome research Software contributions: GcDUO (GC×GC-MS), jHRMSToolBox (HRMS data processing) His publications highlight innovations in data-driven approaches for compound prioritization, toxicity prediction, and method optimization. Recent work explores chemical space exploration and chemometric strategies for complex mixture analysis, with applications to environmental monitoring and forensic science.

• Environmental Chemistry
• Mass Spectrometry
• Non-Targeted Analysis
• +5 more

Prof. Juliette Legler is a Professor of Toxicology at Utrecht University's Institute for Risk Assessment Sciences (IRAS), within the Faculty of Veterinary Medicine. She leads the Division of Toxicology and previously headed the Department of Population Health Sciences (2020–2022). Her research focuses on environmental contaminants' molecular mechanisms, particularly endocrine-disrupting chemicals (EDCs), microplastics, and metabolic disorders. She coordinates major EU projects like GOLIATH (testing metabolism disruptors) and the Microplastics and Human Health Consortium (MOMENTUM), investigating fetal exposure risks. She also leads the Virtual Human Platform for Safety Assessment (VHP4Safety), advancing animal-free testing methods. Education and Career: Before Utrecht, she held roles at Brunel University London (2018) and Vrije Universiteit Amsterdam (2001–2015), where she became a Professor of Toxicology in 2013. She is a European Registered Toxicologist and former President of the Netherlands Society of Toxicology (2019–2022). Research Interests: Her work spans EDC impacts on human and wildlife health, microplastic exposure in fetal environments, and developing in vitro models to replace animal testing. Key projects include the EURION and ENKORE clusters for EDC research and the AFARA project for regulatory acceptance of non-animal assays. Publications and Awards: Over 100 publications, including landmark studies on microplastics and EDCs. Awards include the Poulsson Prize (2018), EUROTOX Lecture Award (2024), and ZonMw Pearl Award for microplastics research. She also received the VENI and VIDI grants from NWO. Grants and Projects: Coordinates €11.4M NWO projects (VHP4Safety, AFARA) and European H2020 initiatives (GOLIATH, AURORA). Her work bridges academia, industry, and policy to address environmental health challenges. Labs/Teams: Active in IRAS, leading cross-disciplinary teams in toxicology, in vitro modeling, and environmental health. Collaborates with global networks like the EURION and AURORA consortia.

• Toxicology
• Endocrinology
• Developmental Biology
• +3 more

Erik Weerts is a Clinician and Veterinary Pathologist (diplomate of the European College of Veterinary Pathologists) at Utrecht University's Faculty of Veterinary Medicine, Department of Biomolecular Health Sciences, Division of Pathology. He holds a PhD in Veterinary Medicine awarded in June 2023 for his thesis 'Coronaviruses in poultry: an ongoing pandemic?' Dr. Weerts' research focuses primarily on veterinary pathology with special emphasis on avian coronaviruses, particularly infectious bronchitis virus in poultry. His work spans comparative pathology, dual infection models, and molecular mechanisms of viral pathogenesis. He has published extensively on coronavirus-related topics, examining viral transmission, tissue tropism, host-pathogen interactions, and vaccine development. Analysis of his recent publications reveals a strong concentration on poultry diseases, particularly viral respiratory infections in chickens and turkeys. His research often examines the interplay between viral and bacterial pathogens, with significant work on infectious bronchitis virus pathogenesis and immune responses. Weerts frequently collaborates with researchers across multiple institutions, demonstrating a network spanning veterinary virology, immunology, and pathology. Diplomate of the European College of Veterinary Pathologists (February 2014) PhD in Veterinary Medicine (June 2023) Dr. Weerts performs diagnostic research including necropsies on domestic, exotic and wild animals, and biopsy examination. He has significant teaching responsibilities within the veterinary medicine program and participates in research collaborations both within and outside the Faculty of Veterinary Medicine, including heat stress in pigs and poultry studies with the Poultry Science Division and Population Health Sciences Department.

• Veterinary Pathology
• Avian Coronavirus Research
• Histopathology
• +4 more

Christian Ramakers is a Researcher in the Department of Clinical Chemistry at Erasmus University Medical Center's Faculty of Medicine. His work bridges laboratory science and clinical practice, focusing on diagnostic innovation and patient-centered biomarker applications across colorectal cancer, infectious diseases, and kidney disorders. His research spans critical medical domains: Colorectal Cancer: Developing home-based monitoring through capillary carcinoembryonic antigen measurements and refining screening methodologies using occult blood tests. Infectious Diseases: Creating rapid mRNA-based diagnostics to differentiate bacterial/viral infections and predict mortality in emergency settings. Nephrology: Investigating dietary impacts (oxalate, potassium) on kidney function in renal disease patients. Endocrinology: Establishing sex-specific reference intervals for serum phosphate in population health. Analysis of his 2024-2025 publications reveals a consistent theme of translating biomarker research into practical clinical tools. Key trends include home-based cancer monitoring systems, emergency department infection diagnostics using host-response mRNA signatures, and precision dietary management for kidney disease. These studies emphasize patient convenience, diagnostic accuracy, and individualized treatment protocols. No scientific awards were documented in the provided materials. The available information does not specify students supervised by Dr. Ramakers or research grants secured. His collaborative work involves multidisciplinary teams across surgery, oncology, nephrology, and emergency medicine, though specific laboratory structures or team compositions remain unreported in the source text.

• Colorectal Cancer
• Infectious Diseases
• Biomarkers
• +3 more

Dr. Jan Nouwen is a faculty researcher at Erasmus MC in the Department of Internal Medicine and Medical Microbiology & Infectious Diseases. His work focuses on HIV-related dermatological alterations, antiretroviral therapy optimization, and microbiome-immune system interactions. Key Research Areas: HIV pathogenesis, antiretroviral drug effects, skin barrier dysfunction, and microbiome changes in immune disorders. Notable Collaborations: ATHENA Observational HIV Cohort, multicohort RESPOND studies. Recent publications highlight his contributions to HIV mortality trends, latency reversal agents, and the role of butyrate in autoimmune conditions like systemic lupus erythematosus. His 2025 review in International Journal of Molecular Sciences synthesizes HIV-associated skin microbiome changes. Scientific Recognition: Recipient of the ICAAC Award (2004) for professional contributions. Methodology: Utilizes prospective cohort studies, clinical trials, and molecular biology approaches.

• HIV Research
• Antiretroviral Therapy
• Dermatology
• +4 more

Merve Atasoy is an External Researcher at Wageningen University & Research, holding a PhD from the Royal Institute of Technology (KTH), awarded in September 2020. Her research focuses on microbial-driven solutions for sustainable resource recovery, wastewater treatment, and circular economy transitions. She specializes in optimizing bioreactors for volatile fatty acid production and studying microbial responses to extreme conditions like low pH environments. Education: PhD in Environmental Biotechnology from Royal Institute of Technology (2017–2021). Awarded on 10 September 2020. Research Interests: Her work integrates microbial community dynamics, bioprocess engineering, and eco-friendly waste valorization strategies. Key areas include enhancing wastewater treatment efficiency, developing nature-based solutions for cities, and leveraging microbial consortia for targeted biochemical production. She explores both fundamental mechanisms (e.g., acid stress responses) and applied technologies (e.g., reactor design). Publications Trends: Recent work emphasizes low-pH microbial systems, circular economy frameworks, and SARS-CoV-2 wastewater surveillance. She has contributed to understanding microbial acid tolerance, optimizing anaerobic bioreactors, and designing sustainable wastewater resource recovery facilities. Collaborations: Active in international networks like the COST Action on acid-impacted microbiology and interdisciplinary teams addressing planetary health through microbial innovation.

• Resource Recovery
• Wastewater Treatment
• Microbial Ecology
• +3 more

Jaap Keijer is a Full Professor and Chairholder in the Department of Human and Animal Physiology at Wageningen University & Research. His research focuses on metabolic physiology, particularly energy metabolism, mitochondrial function, and the interplay between diet, aging, and chronic metabolic diseases. He leads projects investigating nicotinamide nucleotide transhydrogenase (NNT) in energy metabolism, galactose's effects on metabolic programming, and the role of environmental factors like hypoxia in muscle physiology. He serves on the editorial board of Molecular Nutrition and Food Research and advises the German Institute of Human Nutrition. His work integrates molecular, cellular, and whole-organism approaches to understand health and disease mechanisms. Key research themes include metabolic adaptations in obesity, mitochondrial dysfunction in aging, and translational biomarker development for physical activity and metabolic health. Dr. Keijer teaches courses on molecular nutritional physiology, model organisms for lifespan research, and dissection-free human/animal physiology. His projects address clinical challenges such as sarcopenia, atrial fibrillation, and nutrient interventions for metabolic disorders. Recent studies explore dietary galactose's programming effects on intestinal metabolism and the impact of NNT deficiency on cardiac health. His lab employs advanced techniques like single-cell transcriptomics and Seahorse extracellular flux analysis to study metabolic pathways in humans and animal models. Publications emphasize mitochondrial dysfunction, metabolic biomarkers, and translational models for aging and disease. His work bridges basic research and clinical applications, aiming to improve metabolic health through dietary and lifestyle interventions. Current initiatives include developing a human gut-on-a-chip model and validating integrative biomarkers for physical activity in adolescents.

• Energy metabolism
• Mitochondrial function
• Metabolic pathways
• +7 more

Hiroko H. Dodge is a Full Professor of Neurology at Harvard Medical School and serves as Director of Research Analytics at the Interdisciplinary Brain Center, Massachusetts General Hospital (MGH) in Boston, Massachusetts, USA. Her work bridges clinical neurology, data science, and epidemiology with a focus on dementia research. Dr. Dodge's research spans multiple critical areas in aging and cognitive decline, with particular emphasis on clinical trials (both behavioral and pharmacological) in dementia research. Her expertise includes the epidemiology of dementia, application of demographic methods to clinical fields, and advanced data science approaches to understanding cognitive aging. She has made significant contributions to understanding the relationship between social isolation and cognitive decline, as demonstrated through her leadership of the Internet-Based Conversational Engagement Clinical Trial (I-CONECT). Her work explores how social engagement, environmental factors, and nutritional status impact cognitive trajectories in older adults. Dr. Dodge has pioneered research on digital biomarkers for early detection of cognitive impairment, utilizing computerized cognitive testing, speech analysis, and facial expression recognition through projects like the ARMADA study. She has also investigated the role of environmental exposures such as air quality and lead in dementia risk. Editorial Board Member for The Journals of Gerontology Series B Editorial Board Member for Alzheimer's & Dementia Associate Editor for Alzheimer's & Dementia: Translational Research & Clinical Interventions Her research has been widely recognized, with 445 publications that have garnered over 15,000 citations. Dr. Dodge leads innovative clinical trials and methodology development for dementia research, including decentralized trial approaches and synthetic control methods that address challenges in contemporary Alzheimer's disease therapeutic development. She leads "Hiroko Hayama Dodge's Lab" which focuses on innovative approaches to dementia research, particularly through the integration of technology and clinical assessment. Her I-CONECT project, which investigates the impact of frequent social interactions via webcam/internet on cognitive function in socially isolated older adults, represents a novel approach to dementia prevention. Dr. Dodge collaborates extensively with researchers across multiple institutions, with notable partnerships at Oregon Health & Science University and other leading research centers.

• Alzheimer's Disease
• Neurodegeneration
• Mild Cognitive Impairment
• +9 more

Alinda Berends is a Researcher and Teacher at the Pharmacology department within the Faculty of Science at Utrecht University . Her work bridges virology, immunology, and glycobiology.

• Virology
• Immunology
• Glycobiology
• +4 more

Remco Westerink is Associate Professor at Utrecht University's Faculty of Veterinary Medicine and head of the Neurotoxicology Research Group at the Institute for Risk Assessment Sciences (IRAS). His work focuses on cellular and molecular mechanisms of neurotoxicants in food, drugs, and environmental pollutants. Expertise Areas: In vitro toxicology, developmental neurotoxicology, neuropharmacology, microplastics, risk assessment of chemicals Techniques: Multi-electrode arrays, calcium imaging, PC12 cell models, human iPSC-derived neurons Research explores how pollutants like pesticides, flame retardants, and microplastics affect brain development, function, and degeneration through key projects including EU-funded initiatives (TUBE, ENDpoiNTs) and national collaborations. Recent articles highlight his team's work on neurotoxic effects of: Microplastics crossing blood-brain barrier Bisphenols and PFAS disrupting neuronal networks Insecticides altering calcium signaling Organophosphate flame retardants (TCP) linked to aerotoxic syndrome Designer drugs affecting neurotransmission Scientific Contributions: Editorial Board: NeuroToxicology , Toxicology in Vitro Keynote Speaker: 1st International Congress on Global Environmental Contamination (2014) Invited Talks: International Neurotoxicology Association meetings (2012-2017) Westerink leads research into advanced in vitro models to replace animal testing, including development of 48-well microelectrode array platforms and collaborations with Mimetas and RIVM for organ-on-a-chip technology.

• Neurotoxicology
• Toxicology
• In Vitro Toxicology
• +6 more

Prof. Iris Sommer is a Professor of Psychiatry at the University Medical Center Groningen (UMCG) and the University of Groningen. She leads the Clinical Cognitive Neuropsychiatry Research Program (CCNP) and contributes to the Biology-Related, Artificial, and Interventional Neuroscience (BRAIN) group. Her expertise spans neuropsychiatry, with a focus on hallucinations, schizophrenia, and gender disparities in mental healthcare. She is an internationally recognized researcher, having pioneered studies on female brain research, estrogen’s role in psychosis, and innovative treatments like the Stemmenpoli (Voices Clinic). Roles: Editor at Schizophrenia Bulletin, Psychological Medicine, and Lancet Psychiatry. Committee Roles: Chair of ZonMw Offroad Grants Committee, Speaker of the Speakers Academy. Research Interests: Dr. Sommer’s work addresses the origins of psychiatric disorders, particularly schizophrenia and hallucinations. Her key contributions include uncovering estrogen’s protective role in psychotic disorders and advocating for gender-sensitive psychiatric treatments. Recent projects explore gut-brain interactions, probiotics in mental health, and computational linguistics in psychosis diagnosis. Notable Findings: Female brain underrepresentation in clinical studies leads to less effective treatments for women; antipsychotics may suppress beneficial estrogens. Publications & Impact: Over 438 peer-reviewed articles, including high-impact works on hallucinations, COH-FIT pandemic mental health studies, and PET/SPECT imaging in schizophrenia. Her research emphasizes translational medicine and societal impact through public engagement. Awards: Distinguished Lorentz Fellowship (2022/23), Huibregtsenprijs (2022), NWO Science Communication Award (2024), and recognition for science communication initiatives like 'Marvelous Mind.' Labs/Teams: Leads the CCNP, collaborates globally via networks like the HAMLETT and OPHELIA consortia. Active in interdisciplinary projects linking neuroscience, AI, and clinical practice.

• Neuropsychiatry
• Psychiatry
• Schizophrenia
• +5 more

Professor Rinse Weersma is a Full Professor and Gastroenterologist at the Faculty of Medical Sciences, University of Groningen, and works at the University Medical Center Groningen (UMCG). He leads research in the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), focusing on inflammatory bowel diseases and the gut microbiome. Faculty of Medical Sciences, University of Groningen University Medical Center Groningen (UMCG) Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI) Professor Weersma's research primarily centers on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, with a strong emphasis on understanding the role of the gut microbiome, genetic factors, and immune responses. His work bridges gastroenterology, immunology, and microbiology to develop better diagnostic tools and treatment approaches for IBD patients. He has pioneered research on how diet, environmental factors, and host genetics interact to influence disease development and progression. Analysis of Professor Weersma's recent publications (2025) reveals a strong trend toward multi-omics approaches to understanding inflammatory bowel diseases. His research integrates microbiome analysis, genetic studies, and clinical data to identify biomarkers for disease prediction and treatment response. Key themes include the relationship between gut microbiome composition and IBD, gene-environment interactions, and the application of advanced statistical methods to dietary and clinical data. His work has significant implications for personalized medicine approaches in gastroenterology. Rising Star Award (2011) Professor Weersma actively supervises PhD students including Marjolein Klaassen and Laura Bolte, focusing on gut microbiome research in inflammatory bowel diseases. His research is supported by multiple collaborative projects including the 1000IBD project, which has generated extensive multi-omics data from IBD patients. He frequently collaborates with international research teams across Europe and has contributed to major studies on liver transplantation and microbiome interactions. His work has been funded through various national and international grants supporting gastrointestinal research. Professor Weersma leads research within the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), which brings together experts in gastroenterology, immunology, genetics, and microbiome research. His team collaborates extensively through the TransplantLines Investigators consortium and participates in large-scale international research initiatives studying inflammatory bowel diseases across diverse populations.

• Inflammatory Bowel Disease
• Gut Microbiome
• Crohn's Disease
• +5 more

Prof. Stefan Berger is a Professor of Internal Medicine and Transplantation Nephrology at the University of Groningen's Faculty of Medical Sciences. He holds leadership roles including Chair of the Department of Internal Medicine and Board Member of the UMCG Comprehensive Transplant Center. His research focuses on kidney and pancreas transplantation, complement immunology, clinical trials, and immunosuppression strategies. Key areas include transplantation outcomes in elderly patients and mechanisms of graft rejection. He leads studies on health-related quality of life in transplant recipients and the impact of lifestyle interventions post-transplantation. Research interests span translational and clinical studies in transplantation immunology, with emphasis on biomarkers (e.g., complement activation, fibrosis markers) and optimizing immunosuppressive protocols. His work also addresses long-term outcomes in kidney transplant recipients, including graft survival, metabolic complications, and infection risks. Recent articles highlight contributions to understanding complement activation in sepsis, cellular mechanisms of antibody-mediated rejection, and the efficacy of exercise/diet interventions on transplant recipient outcomes. Collaborations involve multidisciplinary teams across nephrology, immunology, and clinical epidemiology. Prof. Berger is actively involved in national and international transplant networks, contributing to policy through roles like Chair of the UMCG Transplant Center and leadership in the Dutch Transplant Foundation. His translational research bridges laboratory findings to clinical practice, aiming to improve transplant recipient care and outcomes.

• Transplantation Immunology
• Nephrology
• Kidney Transplantation
• +4 more